CA2753121A1 - Compositions et procedes pour prevenir et/ou traiter un cancer par pa-card - Google Patents

Compositions et procedes pour prevenir et/ou traiter un cancer par pa-card Download PDF

Info

Publication number
CA2753121A1
CA2753121A1 CA2753121A CA2753121A CA2753121A1 CA 2753121 A1 CA2753121 A1 CA 2753121A1 CA 2753121 A CA2753121 A CA 2753121A CA 2753121 A CA2753121 A CA 2753121A CA 2753121 A1 CA2753121 A1 CA 2753121A1
Authority
CA
Canada
Prior art keywords
cells
laz
peptide
card
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2753121A
Other languages
English (en)
Inventor
Tapas Das Gupta
Ananda Chakrabarty
Arsenio Fiahlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CDG Therapeutics Inc
Original Assignee
CDG Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CDG Therapeutics Inc filed Critical CDG Therapeutics Inc
Publication of CA2753121A1 publication Critical patent/CA2753121A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2753121A 2009-02-20 2010-02-22 Compositions et procedes pour prevenir et/ou traiter un cancer par pa-card Abandoned CA2753121A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15423609P 2009-02-20 2009-02-20
US61/154,236 2009-02-20
US17943509P 2009-05-19 2009-05-19
US61/179,435 2009-05-19
PCT/US2010/024904 WO2010096754A1 (fr) 2009-02-20 2010-02-22 Compositions et procédés pour prévenir et/ou traiter un cancer par pa-card

Publications (1)

Publication Number Publication Date
CA2753121A1 true CA2753121A1 (fr) 2010-08-26

Family

ID=42634238

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2753121A Abandoned CA2753121A1 (fr) 2009-02-20 2010-02-22 Compositions et procedes pour prevenir et/ou traiter un cancer par pa-card

Country Status (9)

Country Link
EP (1) EP2398486A4 (fr)
JP (1) JP2012518417A (fr)
KR (1) KR20120000062A (fr)
CN (1) CN102387809A (fr)
AU (1) AU2010215858A1 (fr)
CA (1) CA2753121A1 (fr)
IL (1) IL214757A0 (fr)
SG (1) SG174136A1 (fr)
WO (1) WO2010096754A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1959986B1 (fr) 2005-11-07 2014-07-23 Indiana University Research and Technology Corporation Analogues de glucagon a solubilite et a stabilite physiologiques ameliorees
WO2014049604A2 (fr) * 2012-09-05 2014-04-03 Amrita Therapeutics Limited Nouveau dispositif biomédical pour la thérapie anticancéreuse
KR101764750B1 (ko) * 2013-02-05 2017-08-03 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 항-마이코플라즈마 에스피피. 아단위 백신
CN103554187B (zh) * 2013-09-18 2016-03-30 中国科学技术大学 铂类配合物、由该铂类化合物制得的蛋白质复合物及其制备方法
USD844857S1 (en) * 2017-10-05 2019-04-02 Western Interlock, Inc. Retaining wall corner block

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2336416T3 (es) * 1999-01-26 2010-04-13 University College London Dimetilarginina dimetilaminohidrolasa.
US20020164703A1 (en) * 2000-12-21 2002-11-07 Krzysztof Pawlowski Card-domain containing polypeptides, encoding nucleic acids, and methods of use
GB0211295D0 (en) * 2002-05-16 2002-06-26 Univ London Treatment of pain
BRPI0515850A (pt) * 2004-10-07 2008-08-12 Ananda Chakrabarty agentes de transportes derivados de cupredoxina e métodos de uso dos mesmos

Also Published As

Publication number Publication date
EP2398486A1 (fr) 2011-12-28
IL214757A0 (en) 2011-11-30
SG174136A1 (en) 2011-10-28
CN102387809A (zh) 2012-03-21
AU2010215858A1 (en) 2011-09-22
WO2010096754A8 (fr) 2011-04-28
JP2012518417A (ja) 2012-08-16
KR20120000062A (ko) 2012-01-03
WO2010096754A1 (fr) 2010-08-26
EP2398486A4 (fr) 2012-11-21

Similar Documents

Publication Publication Date Title
US8545812B2 (en) Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof
US10889621B2 (en) Compositions and methods for treating conditions related to ephrin signaling with Cupredoxins
US10058585B2 (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
CA2753121A1 (fr) Compositions et procedes pour prevenir et/ou traiter un cancer par pa-card
US9968685B2 (en) Methods to treat cancer with cupredoxins
KR20110128878A (ko) 큐프레독신 유래 펩티드의 변형 및 이의 사용방법
US10072049B2 (en) Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
US20100278937A1 (en) Compositions and methods to prevent and/or treat cancer with pa-card
US10675326B2 (en) Compositions comprising cupredoxins for treating cancer
CN101490270A (zh) 用于穿越血脑屏障并进入脑部癌细胞的转运剂及其使用方法
JP2009502797A (ja) 血管形成をキュプレドキシンで制御するための組成物および方法

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140224